These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, Heuss D, Soyka D. Pain; 1994 Nov; 59(2):241-249. PubMed ID: 7892022 [Abstract] [Full Text] [Related]
3. Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache. Bendtsen L, Jensen R, Olesen J. Electroencephalogr Clin Neurophysiol; 1996 Oct; 101(5):418-22. PubMed ID: 8913195 [Abstract] [Full Text] [Related]
4. [Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo]. Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, Wessely P, Zaiser-Kaschel H, Haase W, Fischer W. Nervenarzt; 1993 Feb; 64(2):114-20. PubMed ID: 8450893 [Abstract] [Full Text] [Related]
5. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache. Mathew NT, Kailasam J, Meadors L. Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356 [Abstract] [Full Text] [Related]
6. [The treatment of migraine and tension headaches with amitriptyline (author's transl)]. Pluvinage R. Sem Hop; 2008 Feb; 54(21-24):713-6. PubMed ID: 213837 [Abstract] [Full Text] [Related]
7. [EMG analysis of exteroceptive suppression of temporal muscle activity in tension headache]. Wallasch TM, Reinecke M, Langohr HD. Nervenarzt; 1991 Feb; 62(2):123-6. PubMed ID: 2034307 [Abstract] [Full Text] [Related]
8. Effect of acupuncture-like electrical stimulation on chronic tension-type headache: a randomized, double-blinded, placebo-controlled trial. Wang K, Svensson P, Arendt-Nielsen L. Clin J Pain; 2007 May; 23(4):316-22. PubMed ID: 17449992 [Abstract] [Full Text] [Related]
9. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S. Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864 [Abstract] [Full Text] [Related]
10. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Schulte-Mattler WJ, Krack P, BoNTTH Study Group. Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132 [Abstract] [Full Text] [Related]
11. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group. Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567 [Abstract] [Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
14. [Appraisal of treatment of the trigger points associated with relaxation to treat chronic headache in the adult. Relationship with anxiety and stress adaptation strategies]. Goffaux-Dogniez C, Vanfraechem-Raway R, Verbanck P. Encephale; 2003 Feb; 29(5):377-90. PubMed ID: 14615687 [Abstract] [Full Text] [Related]